A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1274 participants.

Also called NCT02398656

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 1,274 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02398656
Main results
  • Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial Lancet (London, England), 2024-06-15 DOI, PubMed 38768626 PubMed links an erratum for this paper. Erratum: PMID 38879259
Other papers using this trial's data
  • Outcomes After Minor Ischemic Stroke in Older Patients Treated With IV Thrombolysis vs Standard of Care in the TEMPO-2 Trial Neurology, 2026-05-12 DOI, PubMed 41980227
  • Tenecteplase versus standard care for minor ischaemic stroke according to the baseline occlusion status in TEMPO-2 trial European stroke journal, 2026-09-05 DOI, PubMed 42734928, PMC13573578 In the PMC Open Access subset under CC BY.
  • Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical Trial JAMA neurology, 2025-12-01 DOI, PubMed 41143808, PMC12560024 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Australia, Austria, Brazil, Canada, Finland, Ireland, New Zealand, Singapore, Spain, United Kingdom (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02398656. Randomized; single masking; primary purpose treatment. Start 2015-04-01 (actual); primary completion 2024-01-19 (actual). Results posted on 2025-01-31.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Randomized Controlled Trial of TNK-tPA Versus Standard of Care for Minor Ischemic Stroke With Proven Occlusion
Acronym
TEMPO-2
Condition
Stroke, Acute
Intervention (Drug)
Tenecteplase
Intervention (Drug)
Antiplatelet treatment
Lead sponsor
University of Calgary (class: other)

Record details

Record id
cardio:ct-nct02398656
Content hash
dc85fd4e47516b6b1fac1c8cff412f71b829dd703cf8044bbc0af232d582a436